Retapamulin
- Generic Name
- Retapamulin
- Brand Names
- Altabax
- Drug Type
- Small Molecule
- Chemical Formula
- C30H47NO4S
- CAS Number
- 224452-66-8
- Unique Ingredient Identifier
- 4MG6O8991R
- Background
Retapamulin, marketed by GlaxoSmithKline as the ointment Altabax, is an antibiotic for skin infections like impetigo. It was approved by the FDA in April 2007.
- Indication
For use in adults and pediatric patients aged 9 months and older for the topical treatment of impetigo (up to 100 cm in total area in adults or 2% total body surface area in pediatric patients aged 9 months or older) due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes.
- Associated Conditions
- Staphylococcal impetigo, Streptococcal impetigo
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath